SE416466B - Sett att framstella fluorerade amider av nikotinsyra - Google Patents

Sett att framstella fluorerade amider av nikotinsyra

Info

Publication number
SE416466B
SE416466B SE7509692A SE7509692A SE416466B SE 416466 B SE416466 B SE 416466B SE 7509692 A SE7509692 A SE 7509692A SE 7509692 A SE7509692 A SE 7509692A SE 416466 B SE416466 B SE 416466B
Authority
SE
Sweden
Prior art keywords
fluored
amides
make
nicotic acid
nicotic
Prior art date
Application number
SE7509692A
Other languages
English (en)
Swedish (sv)
Other versions
SE7509692L (sv
Inventor
E Diamanti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of SE7509692L publication Critical patent/SE7509692L/xx
Publication of SE416466B publication Critical patent/SE416466B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7509692A 1974-09-05 1975-09-01 Sett att framstella fluorerade amider av nikotinsyra SE416466B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT52879/74A IT1043918B (it) 1974-09-05 1974-09-05 Ammidi fluorurate dell acido nicotinico e procedimento per loro preparazione

Publications (2)

Publication Number Publication Date
SE7509692L SE7509692L (sv) 1976-03-08
SE416466B true SE416466B (sv) 1981-01-05

Family

ID=11278222

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7509692A SE416466B (sv) 1974-09-05 1975-09-01 Sett att framstella fluorerade amider av nikotinsyra

Country Status (7)

Country Link
JP (1) JPS5811865B2 (enrdf_load_stackoverflow)
BE (1) BE833115A (enrdf_load_stackoverflow)
DE (1) DE2534964A1 (enrdf_load_stackoverflow)
FR (1) FR2283680A1 (enrdf_load_stackoverflow)
GB (1) GB1483138A (enrdf_load_stackoverflow)
IT (1) IT1043918B (enrdf_load_stackoverflow)
SE (1) SE416466B (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973597A (en) * 1989-06-30 1990-11-27 Eli Lilly And Company Anticonvulsant agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2365265A (en) * 1941-08-30 1944-12-19 Du Pont Insoluble azo dyes
US3462532A (en) * 1967-08-28 1969-08-19 Dow Chemical Co Controlling gastropods with nicotinanilide or alkylaryl nicotinamide gastropodicides

Also Published As

Publication number Publication date
JPS5811865B2 (ja) 1983-03-04
BE833115A (fr) 1975-12-31
GB1483138A (en) 1977-08-17
IT1043918B (it) 1980-02-29
SE7509692L (sv) 1976-03-08
JPS51125086A (en) 1976-11-01
DE2534964A1 (de) 1976-03-25
FR2283680B1 (enrdf_load_stackoverflow) 1979-08-10
FR2283680A1 (fr) 1976-04-02

Similar Documents

Publication Publication Date Title
SE420204B (sv) Sett att framstella sulfonsyrasalter av s-adenosylmetionin
SE419645B (sv) Sett att framstella 3-amino-indazolkarbonylsyra derivat
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE7607240L (sv) Sett att framstella pyrrolettiksyraforeningar
SE7506743L (sv) Sett att framstella bispidin- och bispidonderivat
SE425244B (sv) Sett att framstella 4-hydroxi-3-kinolin-karboxamidderivat
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE7510329L (sv) Framstellning av 5-fluoro-2-metyl-1-(p-metylsultinylbensyliden)-indenyl-3-ettiksyra
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE7810147L (sv) Sett att framstella cefalosporansyraderivat
SE427655B (sv) Sett att framstella abietamidderivat
SE411447B (sv) Sett att framstella 4-cyklopropylmetylenoxi- 3-klorfenylettiksyra
SE7508779L (sv) Sett att framstella prostaninsyraderivat
FR2299312A1 (fr) Production de dialcanolamines
SE428471B (sv) Sett att framstella imidazolderivat
SE432926B (sv) Sett att framstella disubstituerade fenoletrar av 3-amino-2-hydroxipropan
SE7508561L (sv) Sett att framstella alfa-azidobensylpenicillin
SE412400B (sv) Sett att framstella salter av poly-alfa-hydroxiakrylsyror.
SE404529B (sv) Sett att framstella en diester av 17beta-hydroxi-deltaŸ4-ostren-3-on
SE416466B (sv) Sett att framstella fluorerade amider av nikotinsyra
SE432588B (sv) Sett att framstella substituerade fenyl-alkyl-karboxylsyror
SE425731B (sv) Sett att framstella salter av klorerade ettiksyror.
SE420722B (sv) Sett att framstella benshydryloxi-alkylaminderivat